Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
James Mainwaring's Stock Ratings
Atlantic Equities Analyst
James Mainwaring is an analyst at Atlantic Equities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/24/2025
Overall Average Return
4.62%
Smart Score
Overall Average Return Percentile
48th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/01/2022 | MDT | Buy Now | Medtronic | $80.99 | 29.65% | James Mainwaring43% | $125 → $105 | Downgrade | Overweight → Neutral | Get Alert |
| 10/27/2021 | ABT | Buy Now | Abbott Laboratories | $131.37 | 9.61% | James Mainwaring43% | → $144 | Upgrade | Neutral → Overweight | Get Alert |
| 04/15/2021 | DXCM | Buy Now | DexCom | $82.33 | 432.01% | James Mainwaring43% | → $438 | Initiates | → Overweight | Get Alert |
| 04/15/2021 | EW | Buy Now | Edwards Lifesciences | $74.99 | 13.35% | James Mainwaring43% | → $85 | Initiates | → Neutral | Get Alert |
| 04/15/2021 | ABT | Buy Now | Abbott Laboratories | $131.37 | -7.13% | James Mainwaring43% | → $122 | Initiates | → Neutral | Get Alert |
| 04/15/2021 | MDT | Buy Now | Medtronic | $80.99 | 88.91% | James Mainwaring43% | → $153 | Initiates | → Overweight | Get Alert |
| 03/31/2021 | ILMN | Buy Now | Illumina | $81.08 | 381.01% | James Mainwaring43% | → $390 | Downgrade | Overweight → Neutral | Get Alert |
| 09/30/2020 | ILMN | Buy Now | Illumina | $81.08 | 337.84% | James Mainwaring43% | → $355 | Initiates | → Overweight | Get Alert |
